ASO Author Reflections: Indolent Growth and Small Bowel Neuroendocrine Tumor Management

Area of Science:

• Oncology
• Surgical Oncology
• Gastroenterology

Background:

• Surgical treatment is a cornerstone in managing small bowel neuroendocrine tumors (SBNETs).
• Current clinical practice involves significant debate regarding the optimal surgical approach.
• Key areas of controversy include resection of asymptomatic primary tumors with unresectable metastases, the utility of minimally invasive surgery, and the integration of medical therapies.

Purpose of the Study:

• To highlight the ongoing controversies in the surgical management of SBNETs.
• To identify barriers to conducting high-quality randomized surgical trials for SBNETs.
• To propose a path forward for establishing evidence-based surgical guidelines.

Main Methods:

• This abstract discusses existing challenges and proposes future directions based on current clinical knowledge.
• It emphasizes the need for collaborative efforts among experienced clinicians at high-volume centers.
• The focus is on designing randomized trials to resolve surgical management uncertainties.

Main Results:

• Conducting randomized surgical trials for SBNETs is hindered by low incidence, long event times, and variability in disease presentation and treatment approaches.
• Increasing patient referrals to specialized centers facilitate collaboration.
• Cooperation among experienced clinicians is essential for designing robust trials.

Conclusions:

• Addressing surgical controversies in SBNET management requires high-quality evidence from randomized trials.
• Collaboration between experienced clinicians at high-volume centers is crucial for trial design and execution.
• Future research should focus on resolving key surgical questions to optimize patient outcomes.